Back to top
  • Open Daily at 10am
  • Call Ahead for Curbside Pickup
  • 443-438-3659

Cannabidiolic Acid (CBDA): Everything You Need to Know

Exploring the World of Cannabidiolic Acid (CBDA)

Cannabidiolic Acid (CBDA) is a lesser-known cannabinoid found in Cannabis sativa L., but it’s quickly gaining recognition for its potential benefits. This acid precursor to CBD offers a unique perspective into the world of cannabinoids. Let’s take a closer look at what CBDA is, how it differs from CBD, and its potential applications.

What is CBDA?

CBDA, short for cannabidiolic acid, is a natural compound that exists inside cannabis and hemp plants. Only present in living plant matter, CBDA quickly converts to CBD when exposed to heat. While CBDA may not be as well-known as CBD, it plays a crucial role in the cannabinoid family. Without CBDA, we would never have the versatile wellness compound CBD that we know today.

Where does CBDA come from?

Inside the hemp plant, a diverse family of cannabinoids exists, with CBGA being the primary compound early on. As the plant matures, CBGA combines with an acid compound to give rise to three new members of the cannabinoid family: CBDA, CBCA, and THCA. CBDA is the acid precursor to CBD, and it undergoes decarboxylation to convert to CBD when exposed to high temperatures.

What is the difference between CBDA and CBD?

While CBDA is the precursor to CBD, it offers unique characteristics of its own. CBDA is primarily found in raw plant material and is less stable than CBD on a chemical level because of the carboxyl group it contains. Initial research suggests that CBDA has a greater affinity for certain receptors and enzymes in the body compared to CBD.

How does CBDA work?

CBDA primarily interacts with the endocannabinoid system and its receptors in the body. It shows potential for binding to serotonin receptors and inhibiting the COX-2 enzyme, which is linked to inflammation. While research is still in the early stages, CBDA is being studied for its potential effects on anxiety, nausea, inflammation, cancer cells, and even in combating COVID-19.

As cannabinoid research continues to evolve, CBDA is emerging as a promising compound with valuable applications. Further clinical investigations are needed to fully understand the potential benefits of CBDA. With increasing interest in cannabinoids, we can anticipate exciting developments in the field of cannabis research in the near future.

For those interested in exploring the benefits of CBDA, products containing this compound are legal in Europe and the United States. The differences between CBDA and CBD extend beyond their chemical structures to how they interact with the human body. Stay informed about the ever-expanding world of cannabinoids to discover the full potential of these fascinating compounds.

Sources

[1] Formato M, Crescente G, Scognamiglio M, et al. (‒)-cannabidiolic acid, a still overlooked bioactive compound: An introductory review and preliminary research. Molecules (Basel, Switzerland). [Source]

[2] Russo EB. Cannabis therapeutics and the future of neurology. Frontiers in integrative neuroscience. [Source]

[3] Russo EB. Cannabis therapeutics and the future of neurology. Frontiers in integrative neuroscience. [Source]

[4] Pertwee RG, Rock EM, Guenther K, et al. BPS Publications. British Pharmacological Society | Journals. [Source]

[5] K; TSMKYIW. Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in Cannabis. Drug metabolism and disposition: the biological fate of chemicals. [Source]

[6] Ligresti A, Moriello AS, Starowicz K, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Journal of Pharmacology and Experimental Therapeutics. [Source]

[7] Takeda S, Okajima S, Miyoshi H, et al. Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Toxicology Letters. [Source]

[8] van Breemen RB;Muchiri RN;Bates TA;Weinstein JB;Leier HC;Farley S;Tafesse FG; R. Cannabinoids block cellular entry of SARS-COV-2 and the emerging variants. Journal of natural products. [Source]